Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Arcutis Biotherapeutics Inc., 3 years.
Arcutis Biotherapeutics Inc.
Director
Mirum Pharmaceuticals Inc.
Director
MBX Biosciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2024 | Mirum Pharmaceuticals Inc. | Open-market purchase | +115 | $37.40 | $4,301 |
| Sep 16, 2024 | MBX Biosciences Inc. | Derivative conversion | +3,927,774 | — | — |
| Sep 16, 2024 | MBX Biosciences Inc. | Open-market purchase | +625,000 | $16.00 | $10,000,000 |
| Sep 6, 2024 | Mirum Pharmaceuticals Inc. | Open-market purchase | +230 | $41.58 | $9,563 |
| Jun 14, 2024 | Arcutis Biotherapeutics Inc. | Grant or award | +10,139 | — | — |
| Mar 4, 2024 | Arcutis Biotherapeutics Inc. | Open-market purchase | +21,052 | $9.50 | $199,994 |
| Nov 9, 2023 | Mirum Pharmaceuticals Inc. | Open-market purchase | +2,910 | $28.30 | $82,353 |
| Oct 24, 2023 | Arcutis Biotherapeutics Inc. | Open-market purchase | +80,000 | $2.50 | $200,000 |
| Sep 13, 2023 | Mirum Pharmaceuticals Inc. | Open-market purchase | +2,625 | $31.02 | $81,428 |
| Sep 12, 2023 | Mirum Pharmaceuticals Inc. | Open-market purchase | +3,750 | $30.60 | $114,750 |
| Sep 11, 2023 | Mirum Pharmaceuticals Inc. | Open-market purchase | +4,687 | $30.30 | $142,016 |
| Aug 31, 2023 | Mirum Pharmaceuticals Inc. | Open-market purchase | +147,991 | $26.25 | $3,884,764 |
| May 31, 2023 | Arcutis Biotherapeutics Inc. | Grant or award | +4,375 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.